The members of the Corporate Relations
Committee (CRC) of SIMSREE had the opportunity to interview Mr. Chandrashekhar
Tatapudy, CEO and Co-founder of Yasham Life Sciences Private Ltd. on the
27th of September, 2013. He is also currently a business Advisor to Carlson
Caspers, a US based law firm, Eduriser Learning Solutions Pvt. Ltd., an
education content delivery company, VSBT, Baramati a biotech institute, Cool
Flo Engineers Pvt. Ltd., a manufacture of large industrial fans for cooling
towers and TDK & Co, a chartered accountancy firm.
Mr. Tatapudy has 33 years (27 years in the
US and 6 years between India and the US) of successful experience as a strategy
consultant (6 years), entrepreneur, co-founder and CFO of two California
Silicon Valley based software companies (12 years) and engineering consultant
(15 years). Mr.Tatapudy specializes in India-Entry strategies for US companies
and in US entry for India-based companies. He has authored ‘Gujarat Sails
to Success’ for the Gujarat State Government, a book released at Vibrant Gujarat,
2007.
Mr. Tatapudy’s experience spans across
bioscience, pharmaceuticals, energy, software, infrastructure, education and
engineering industries and in companies from large to small. He has
worked in the Bay Area (California), New York City, Mumbai and Hyderabad.
Excerpts from the interview:
Team CRC: What according to you are the
entry barriers for budding entrepreneurs who wish to enter into the field of
bio-technology or pharmacy?
Mr. Tatapudy: In India, it is difficult to start any
kind of business because of limited scope but the Department of Biotechnology
(DBT) which is a Government body has been very supportive. It provides
subsidies and good schemes to attractive projects. A combination of science and
management will definitely help the young entrepreneurs having innovative ideas
to excel in their business.
CRC: What qualities do young entrepreneurs
who want to open up a start-up need to have?
Mr. Tatapudy: Youngsters should first test themselves
for finding out whether they have the attitude of being an entrepreneur or not.
Self-belief is one thing that makes you do wonders. They need to have passion
and the attitude to work towards their beliefs. They should be clear with their
thought process and think and plan how to make the optimum use of the limited
resources.
CRC: The parliament aims to come up with a
regulatory body named Central Drug Authority which will be in lines with Food
and Drug Administration, USA. What are your views on this?
Mr. Tatapudy: This kind of regulatory body will
definitely be helpful. People in this sector will be more organised and
committed. However, what I feel is that seriousness on legal end is
required. For this India has to improve itself on law enforcement. Unless this
system is in place, the enforcement and implementation of the regulatory body
would be a problematic.
CRC: According to recent report by Ernst
and Young, biotech sector in India is expected to achieve revenue of $ 11.6
billion by 2017 whereas the current economic scenario shows a slowdown where
India is growing at a GDP of less than 5%. What according to you will be the
future of the biotech sector in India?
Mr. Tatapudy: I am not sure about that statistics but
yes the sector is bound to grow at rapid rate in the years to come. We can't
relate this growth to India's GDP growth because most of the revenue will be
generated through exports. Though, domestic sales in this industry will be low
in next few years, it will thrive on international business. In fact I would
suggest young MBA graduates to join pharmaceutical sector. So the future of
this sector is really bright.
CRC: As you have stayed in USA as well as
India for long durations, so how will you relate India's growth post independence
to that of USA
Mr. Tatapudy: India has developed lot
post-independence. India had lady prime minister and adopted secular stance in
very early years. The democracy is India's backbone. The demographic capital of
India will help it further as compared to USA. Also the democratic system gives
it edge over China. In the long run India will be more stable than China. India
has a lot of influence in African continent. As Africa will grow the India will
prosper.
CRC: As we know there is a huge scope of
exports from this sector. But is there any corresponding import too?
Mr. Tatapudy: Yes we do import some items from
different countries across the world. But imports form a very minor part.
Actually the biotech sector has very smart people. They use research and
management very well to generate revenues. They have to deal with different
litigations and law systems in different countries. Thus R&D, management
and law play measure role in success of this industry. So a small per
cent of imports does not make a big difference.
CRC: Is there any benefit that the
pharmaceutical sector gains because of Medical Tourism?
Mr. Tatapudy: Yes we can say that the sector is at an
advantage due to Medical Tourism. This is mainly because of the good services
that are provided in time and with lower costs. In some of the western
countries, the waiting list for the patients is too long. This pulls people
from abroad for treatment of various diseases. However there exist problems
in litigations. If any foreigner sues any hospital or a doctor then their money
will be at stake. Indians are not used to this. The penalty that has to be paid
can be huge. So here insurance sector comes into play. Please note that, in
India, this is another sector which will grow tremendously.
CRC: Is India’s population an asset
according to you?
Mr. Tatapudy: Population of India is often referred to
as Demographic Dividend. However in my opinion currently India’s population is
the Demographic Capital. There are some major problems in the economy like
corruption, lenient judiciary system, etc. but every economy passes through
similar stages. India’s growth in post-independence period has been outstanding
and there is larger scope of India beating China in long run.
CRC: What are your suggestions for the
first year MBA students? What according to you can make them industry ready?
Mr. Tatapudy: Frankly, the real battle starts at work.
Working in corporate world gives you more learning than any kind of textbook.
Another important thing is observing actions of people around and learning from
them. Believe in your gut feeling and take decisions by following your
intuitions.
CRC: It has been a pleasure talking
to you, sir. Thank you for sharing your valuable time with us.
4 comments:
It was indeed a great experience talking to Mr.Tatapudy, a man with such a diverse profile. The insights that sir gave us will be very useful for us to understand the biotech industry and its future.
Amazing guys nice thinking.
Its really a great post and thanks for sharing the information with us.
Startup Consultants in India | India Entry Strategy Companie
Nice Blog and it is very informative!!!
seo training in bangalore
Post a Comment